CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Catechin

儿茶素 杂质对照品Catechin Impurities

21 个杂质条目21 impurity entries

本页汇总 儿茶素 的 21 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 21 impurity reference standards of Catechin. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 儿茶素(Catechin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesMicroemulsion formulation design and evaluation for hydrophobic compound: Catechin topical application
    Colloids and surfaces. B, Biointerfaces · 2018 · Lin YH et al.  ·  PMID 29055864  ·  DOI
  2. 分析方法Analytical MethodsDevelopment and validation of UHPLC-MS/MS method for determination of eight naturally occurring catechin derivatives in various tea samples and the role of matrix effects
    Journal of pharmaceutical and biomedical analysis · 2015 · Svoboda P et al.  ·  PMID 26025813  ·  DOI
  3. 分析方法Analytical MethodsMethod development and validation for rapid identification of epigallocatechin gallate using ultra-high performance liquid chromatography
    PloS one · 2020 · U V R et al.  ·  PMID 31940329  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisConcise Synthesis of Catechin Metabolites 5-(3',4'-Dihydroxyphenyl)-γ-valerolactones (DHPV) in Optically Pure Form and Their Stereochemical Effects on Skin Wrinkle-Reducing Activities
    Molecules (Basel, Switzerland) · 2020 · Hur J et al.  ·  PMID 32340245  ·  DOI
  • 合成方法SynthesisConcise synthesis of catechin probes enabling analysis and imaging of EGCg
    Chemical communications (Cambridge, England) · 2011 · Yoshida A et al.  ·  PMID 21132166  ·  DOI

儿茶素 —— 原料药与杂质对照品Catechin — drug substance & impurities

共 22 个条目(含原料药本体)22 items incl. the drug substance
Catechin structure
原料药 APIAPI
儿茶素Catechin
Catechin
CAS No.154-23-4
Chemical FormulaC15H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 1 ((-)-Epigallocatechin Gallate) (EGCG) structure
1
儿茶素杂质1 ((-)-表没食子儿茶素没食子酸酯)Catechin Impurity 1 ((-)-Epigallocatechin Gallate) (EGCG)
Catechin Impurity 1 ((-)-Epigallocatechin Gallate) (EGCG)
CAS No.989-51-5
Chemical FormulaC22H18O11
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 2 ((-)-Epigallocatechin) structure
2
儿茶素杂质2 ((-)-表没食子儿茶素)Catechin Impurity 2 ((-)-Epigallocatechin)
Catechin Impurity 2 ((-)-Epigallocatechin)
CAS No.970-74-1
Chemical FormulaC15H14O7
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 3 ((-)-Epicatechin Gallate) structure
3
儿茶素杂质3 ((-)-表儿茶素没食子酸酯)Catechin Impurity 3 ((-)-Epicatechin Gallate)
Catechin Impurity 3 ((-)-Epicatechin Gallate)
CAS No.1257-08-5
Chemical FormulaC22H18O10
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 4 ((-)-Epicatechin) structure
4
儿茶素杂质4 ((-)-表儿茶素)Catechin Impurity 4 ((-)-Epicatechin)
Catechin Impurity 4 ((-)-Epicatechin)
CAS No.490-46-0
Chemical FormulaC15H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 5 ((-)-Gallocatechin Gallate) structure
5
儿茶素杂质5 ((-)-没食子儿茶素没食子酸酯)Catechin Impurity 5 ((-)-Gallocatechin Gallate)
Catechin Impurity 5 ((-)-Gallocatechin Gallate)
CAS No.4233-96-9
Chemical FormulaC22H18O11
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 6 ((-)-Catechin Gallate) structure
6
儿茶素杂质6 ((-)-儿茶素没食子酸酯)Catechin Impurity 6 ((-)-Catechin Gallate)
Catechin Impurity 6 ((-)-Catechin Gallate)
CAS No.130405-40-2
Chemical FormulaC22H18O10
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 7 ((−)-Gallocatechin) structure
7
儿茶素杂质7 ((−)-倍儿茶酸)Catechin Impurity 7 ((−)-Gallocatechin)
Catechin Impurity 7 ((−)-Gallocatechin)
CAS No.3371-27-5
Chemical FormulaC15H14O7
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 8 structure
8
儿茶素杂质8Catechin Impurity 8
Catechin Impurity 8
CAS No.42830-48-8
Chemical FormulaC20H22O10
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 9 structure
9
儿茶素杂质9Catechin Impurity 9
Catechin Impurity 9
CAS No.69912-75-0
Chemical FormulaC16H16O6
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 10 structure
10
儿茶素杂质10Catechin Impurity 10
Catechin Impurity 10
CAS No.18829-70-4
Chemical FormulaC15H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 11 (Epicatechin) structure
11
儿茶素杂质11(表儿茶酸)Catechin Impurity 11 (Epicatechin)
Catechin Impurity 11 (Epicatechin)
CAS No.35323-91-2
Chemical FormulaC15H14O6
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 12 structure
12
儿茶素杂质12Catechin Impurity 12
Catechin Impurity 12
CAS No.1194378-94-3
Chemical FormulaC15H14O9S
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 13 structure
13
儿茶素杂质13Catechin Impurity 13
Catechin Impurity 13
CAS No.116183-66-5
Chemical FormulaC28H32O16
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 14(Procyanidin) structure
14
儿茶素杂质14(原花青素)Catechin Impurity 14(Procyanidin)
Catechin Impurity 14(Procyanidin)
CAS No.20347-71-1
Chemical FormulaC30H26O13
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 15 structure
15
儿茶素杂质15Catechin Impurity 15
Catechin Impurity 15
CAS No.65597-47-9
Chemical FormulaC21H24O11
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 16 structure
16
儿茶素杂质16Catechin Impurity 16
Catechin Impurity 16
CAS No.81905-13-7
Chemical FormulaC20H22O10
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 17 structure
17
儿茶素杂质17Catechin Impurity 17
Catechin Impurity 17
CAS No.55167-29-8
Chemical FormulaC15H14O5
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 18 (Theasinensin A) structure
18
儿茶素杂质18 (聚酯型儿茶素A)Catechin Impurity 18 (Theasinensin A)
Catechin Impurity 18 (Theasinensin A)
CAS No.89064-31-3
Chemical FormulaC44H34O22
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 19 (3′-O-Methylepicatechin) structure
19
儿茶素杂质19 (3′- O -甲基表儿茶素)Catechin Impurity 19 (3′-O-Methylepicatechin)
Catechin Impurity 19 (3′-O-Methylepicatechin)
CAS No.76549-34-3
Chemical FormulaC16H16O6
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 21 structure
21
儿茶素杂质21Catechin Impurity 21
Catechin Impurity 21
CAS No.1273593-15-9
Chemical FormulaC14H12O6
Purity>95%询价On request
10mg25mg50mg100mg
Catechin Impurity 22 structure
22
儿茶素杂质22Catechin Impurity 22
Catechin Impurity 22
CAS No.98-29-3
Chemical FormulaC10H14O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

儿茶素 —— 研究文献与合成路线Catechin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 儿茶素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Catechin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Oxidation and degradation of (epi)gallocatechin gallate (EGCG/GCG) and (epi)catechin gallate (ECG/CG) in alkali solution
    Peng H, Shahidi F · Food chemistry · 2023 · 被引 39cited 39
  2. Protection of β-carotene from chemical degradation in emulsion-based delivery systems using antioxidant interfacial complexes: Catechin-egg white protein conjugates
    Gu L, Su Y, Zhang M, et al. · Food research international (Ottawa, Ont.) · 2017 · 被引 74cited 74
  3. Formation of pigment precursor (+)-1''-methylene-6''-hydroxy-2H-furan-5''-one-catechin isomers from (+)-catechin and a degradation product of ascorbic acid in a model wine system
    Barril C, Clark AC, Prenzler PD, et al. · Journal of agricultural and food chemistry · 2009 · 被引 20cited 20
  4. Protection of ascorbic acid from copper(II)-catalyzed oxidative degradation in the presence of flavonoids: quercetin, catechin and morin
    Beker BY, Sönmezoğlu I, Imer F, et al. · International journal of food sciences and nutrition · 2011 · 被引 15cited 15
  5. Improvement of the fermentation performance of Lactobacillus plantarum by the flavanol catechin is uncoupled from its degradation
    López de Felipe F, Curiel JA, Muñoz R · Journal of applied microbiology · 2010 · 被引 15cited 15
  6. Biotransformation of (+)-catechin into taxifolin by a two-step oxidation: primary stage of (+)-catechin metabolism by a novel (+)-catechin-degrading bacteria, Burkholderia sp. KTC-1, isolated from tropical peat
    Matsuda M, Otsuka Y, Jin S, et al. · Biochemical and biophysical research communications · 2008 · 被引 9cited 9

合成与制备工艺专利Synthesis & process patents

  1. PHARMACEUTICAL PREPARATION COMPRISING A CATECHIN
    LARKINS NICHOLAS JOHN · 公开号 WO2010026375WO2010026375 · 2010
  2. Process for preparing methylation catechin by tea
    ZHENGLI GONG, ZHENGFEI LUO, JIAN YANG, HUARONG TONG, et al. · 公开号 CN101177422CN101177422 · 2008
  3. Method for preparing multiple catechin monomers by separation of tea polyphenol or catechin mixing system
    CHUNSHAN ZHOU, SHENGHUA ZHANG, XIAOFEN ZHOU · 公开号 CN101503400CN101503400 · 2009
  4. PROCESS FOR EFFICIENTLY PRODUCING ALKYLATED CATECHIN
    KAN TOSHIYUKI, FURUTA TAKUMI, WAKIMOTO TOSHIYUKI · 公开号 WO2010067599WO2010067599 · 2010
  5. USE OF CATECHIN IN PREPARATION OF RETROVIRUS INTEGRASE INHIBITOR
    ZHAO YALI, JIANG FAN, YI KEJIA · 公开号 WO2010108410WO2010108410 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

儿茶素 杂质谱研究要点Catechin — impurity profiling notes

下面这些是拿到 儿茶素 的 22 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 22 impurity entries for Catechin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances